2026 funding rounds and state support across AI, robotics and biotech
Recent capital raises and government contracts highlight investment activity in artificial intelligence, robotics and biotechnology during 2026.
Compiled automatically from the sources listed below and checked against Hyperuranios' own capital and research data. Every figure here traces to a linked source. Factual errors reported to the contact address are corrected in the article and noted here.
Artificial Intelligence
Thinking Machines Lab, founded by former OpenAI CTO Mira Murati, is negotiating a minimum $1 billion financing at a pre‑money valuation of roughly $40 billion, with existing backer Accel leading the round and Nvidia reportedly in talks to join, after releasing its first model Inkling in July and being less than two years old [1].
Munich‑based Atira, which automates industrial sales‑engineering using AI agents that read and respond to complex bid requests, closed a $17.5 million round comprising a $15 million seed led by Accel and a $2.5 million pre‑seed, with participation from UVC Partners, Fortino, BOOOM and individual investors such as Marc Bitzer and Bastian Nominacher; the company plans to expand its quoting platform across its early customer base of about 15 firms [4].
Egyptian edtech firm 3C Coding School raised a $3 million seed round led by MRG Economic Group, joined by investor Amr Saad and several angel backers, to fund expansion into Saudi Arabia and accelerate development of its AI‑powered personalised learning platform that tailors coding, data science and AI curricula to individual learners’ progress [5].
Robotics
Singapore robotics startup Hivebotics secured $6 million in a Series A led by Vertex Ventures Southeast Asia & India, with participation from Fareast Land Development and Rigel, to move its restroom‑cleaning robot Abluo from pilot deployments to large‑scale production, broaden its distribution network across four core markets and develop a proprietary physical‑AI layer for planning and validation of cleaning jobs [2].
Genetic Engineering
Polish deep‑tech biotech Science4Beauty raised €1.6 million in a round led by 4growth VC with participation from Hard2beat and angels, to scale production and sales of its conotoxin‑based skincare line Miorelaxant Magic™, pursue R&D into new bioactive peptides for applications like hyperhidrosis and rosacea, and expand internationally, leveraging its in‑house recombinant protein technology [3].